Literature DB >> 29059354

Inflammation and Fibrosis in Perirenal Adipose Tissue of Patients With Aldosterone-Producing Adenoma.

Chunyan Wu1, Huijian Zhang2, Jiajun Zhang3, Cuihua Xie1, Cunxia Fan1, Hongbin Zhang4, Peng Wu2, Qiang Wei2, Wanlong Tan2, Lingling Xu1, Ling Wang1, Yaoming Xue1, Meiping Guan1.   

Abstract

The prevalence of primary aldosteronism is much higher than previously thought. Recent studies have shown that primary aldosteronism is related to a higher risk of cardiovascular events. However, the underlying mechanism is not yet clear. Here we investigate the characteristics, including inflammation, fibrosis, and adipokine expression, of adipose tissues from different deposits in patients with aldosterone-producing adenoma (APA). Inflammation and fibrosis changes were evaluated in perirenal and subcutaneous adipose tissues obtained from patients with APA (n = 16), normotension (NT; n = 10), and essential hypertension (EH; n = 5) undergoing laparoscopic surgery. We also evaluated the effect of aldosterone in isolated human perirenal adipose tissue stromal vascular fraction (SVF) cells and investigated the effect of aldosterone in mouse 3T3-L1 and brown preadipocytes. Compared with the EH group, significantly higher levels of interleukin-6 (IL-6) and tumor necrosis factor-α messenger RNA (mRNA) and protein were observed in perirenal adipose tissue of patients with APA. Expression of genes related to fibrosis and adipogenesis in perirenal adipose tissue was notably higher in patients with APA than in patients with NT and EH. Aldosterone significantly induced IL-6 and fibrosis gene mRNA expression in differentiated SVF cells. Aldosterone treatment enhanced mRNA expression of genes associated with inflammation and fibrosis and stimulated differentiation of 3T3-L1 and brown preadipocytes. In conclusion, these data indicate that high aldosterone in patients with APA may induce perirenal adipose tissue dysfunction and lead to inflammation and fibrosis, which may be involved in the high risk of cardiovascular events observed in patients with primary aldosteronism.
Copyright © 2018 Endocrine Society.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29059354     DOI: 10.1210/en.2017-00651

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  11 in total

1.  Sex-specific Association of Primary Aldosteronism With Visceral Adiposity.

Authors:  Yu Hatano; Nagisa Sawayama; Hiroshi Miyashita; Tomoyuki Kurashina; Kenta Okada; Manabu Takahashi; Masatoshi Matsumoto; Satoshi Hoshide; Takahiro Sasaki; Shuichi Nagashima; Ken Ebihara; Harushi Mori; Kazuomi Kario; Shun Ishibashi
Journal:  J Endocr Soc       Date:  2022-06-25

2.  Risk Factors Associated With Lower Bone Mineral Density in Primary Aldosteronism Patients.

Authors:  Xiaomei Lv; Huijun Hu; Chuyu Shen; Xiaoyun Zhang; Li Yan; Shaoling Zhang; Ying Guo
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-16       Impact factor: 6.055

Review 3.  Perirenal Adipose Tissue Inflammation: Novel Insights Linking Metabolic Dysfunction to Renal Diseases.

Authors:  Safaa H Hammoud; Ibrahim AlZaim; Yusra Al-Dhaheri; Ali H Eid; Ahmed F El-Yazbi
Journal:  Front Endocrinol (Lausanne)       Date:  2021-08-02       Impact factor: 5.555

4.  Association of visceral adiposity and clinical outcome among patients with aldosterone producing adenoma.

Authors:  Leay Kiaw Er; Meng-Chun Lin; Yao-Chou Tsai; Jong-Kai Hsiao; Chung-Yi Yang; Chin-Chen Chang; Kang-Yung Peng; Jeff S Chueh; Vin-Cent Wu
Journal:  BMJ Open Diabetes Res Care       Date:  2020-07

Review 5.  Characterization of the inflammatory-metabolic phenotype of heart failure with a preserved ejection fraction: a hypothesis to explain influence of sex on the evolution and potential treatment of the disease.

Authors:  Milton Packer; Carolyn S P Lam; Lars H Lund; Mathew S Maurer; Barry A Borlaug
Journal:  Eur J Heart Fail       Date:  2020-06-26       Impact factor: 15.534

Review 6.  Cerebro-Cardiovascular Risk, Target Organ Damage, and Treatment Outcomes in Primary Aldosteronism.

Authors:  Xiao Lin; Muhammad Hasnain Ehsan Ullah; Xiong Wu; Feng Xu; Su-Kang Shan; Li-Min Lei; Ling-Qing Yuan; Jun Liu
Journal:  Front Cardiovasc Med       Date:  2022-02-02

7.  Exendin-4 Improves Diabetic Kidney Disease in C57BL/6 Mice Independent of Brown Adipose Tissue Activation.

Authors:  Shu Fang; Yingying Cai; Fuping Lyu; Hongbin Zhang; Chunyan Wu; Yanmei Zeng; Cunxia Fan; Shaozhou Zou; Yudan Zhang; Ping Li; Ling Wang; Meiping Guan
Journal:  J Diabetes Res       Date:  2020-02-03       Impact factor: 4.011

8.  Increased oxidative stress, inflammation and fibrosis in perirenal adipose tissue of patients with cortisol-producing adenoma.

Authors:  Chunyan Wu; Huijian Zhang; Jiajun Zhang; Hongbin Zhang; Yanmei Zeng; Shu Fang; Ping Li; Yudan Zhang; Xiaochun Lin; Ling Wang; Yaoming Xue; Meiping Guan
Journal:  Adipocyte       Date:  2019-12       Impact factor: 4.534

Review 9.  Metabolic Dysregulation in Idiopathic Pulmonary Fibrosis.

Authors:  Elena Bargagli; Rosa Metella Refini; Miriana d'Alessandro; Laura Bergantini; Paolo Cameli; Lorenza Vantaggiato; Luca Bini; Claudia Landi
Journal:  Int J Mol Sci       Date:  2020-08-07       Impact factor: 5.923

10.  Evaluation of Abdominal Computed Tomography Scans for Differentiating the Discrepancies in Abdominal Adipose Tissue Between Two Major Subtypes of Primary Aldosteronism.

Authors:  Kuan-Ming Chen; Bo-Ching Lee; Po-Ting Chen; Kao-Lang Liu; Kuan-Heng Lin; Chin-Chen Chang; Tung-Hsin Wu; Jia-Sheng Hong; Yen-Hung Lin
Journal:  Front Endocrinol (Lausanne)       Date:  2021-07-16       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.